- A medical research team in Guntur, Andhra Pradesh, successfully utilized phage therapy to treat drug-resistant bacterial infections, offering a promising alternative as conventional antibiotics fail. - Phage therapy uses bacteriophages (viruses that specifically target and kill bacteria) to combat multidrug-resistant (MDR) pathogens without harming human cells or beneficial microbiota. - This development addresses the global and national public health threat of Antimicrobial Resistance (AMR), often called the 'silent pandemic'. - It highlights the need for institutional support, clinical trials, and regulatory frameworks to mainstream alternative therapies against superbugs. - **National Action Plan on Antimicrobial Resistance (NAP-AMR):** India's comprehensive multi-sectoral roadmap aligned with the WHO Global Action Plan, utilizing a One Health approach to curb the escalating public health threat of drug-resistant pathogens. - **Guntur medical team:** A medical research group in Andhra Pradesh that successfully utilized bacteriophage therapy to treat patients with persistent, multidrug-resistant bacterial infections. **Introduction** A medical team in Guntur, Andhra Pradesh, has reported successful clinical outcomes using phage therapy to treat drug-resistant bacterial infections. This breakthrough offers a viable alternative to conventional antibiotics amidst the escalating global threat of Antimicrobial Resistance (AMR), highlighting the potential of bacteriophages in targeting superbugs. **Core Issue and Detailed Points** - A medical research team in Guntur, Andhra Pradesh, successfully utilized phage therapy to treat drug-resistant bacterial infections, offering a promising alternative as conventional antibiotics fail. - Phage therapy uses bacteriophages (viruses that specifically target and kill bacteria) to combat multidrug-resistant (MDR) pathogens without harming human cells or beneficial microbiota. - This development addresses the global and national public health threat of Antimicrobial Resistance (AMR), often called the 'silent pandemic'. - It highlights the need for institutional support, clinical trials, and regulatory frameworks to mainstream alternative therapies against superbugs. **Key Statutory Bodies, Acts & Concepts** - **National Action Plan on Antimicrobial Resistance (NAP-AMR):** India's comprehensive multi-sectoral roadmap aligned with the WHO Global Action Plan, utilizing a One Health approach to curb the escalating public health threat of drug-resistant pathogens. - **Guntur medical team:** A medical research group in Andhra Pradesh that successfully utilized bacteriophage therapy to treat patients with persistent, multidrug-resistant bacterial infections.